藥華藥(6446)  114年 第3季 綜合損益表民國114年第3季 單位：新台幣仟元 會計項目114年第3季113年第3季本期累計去年同期累計 金額%金額%金額%金額%營業收入        　營業收入合計3,893,772100.002,713,359100.0010,753,539100.006,673,280100.00營業成本        　營業成本合計327,9278.42327,88612.081,140,64810.61821,50612.31營業毛利（毛損）3,565,84591.582,385,47387.929,612,89189.395,851,77487.69營業毛利（毛損）淨額3,565,84591.582,385,47387.929,612,89189.395,851,77487.69營業費用        　推銷費用960,91324.68563,35020.762,378,44022.121,630,49224.43　管理費用554,42414.24384,39414.171,407,30613.091,206,69418.08　研究發展費用884,62722.72703,20025.922,460,39422.881,819,92927.27　營業費用合計2,399,96461.641,650,94460.856,246,14058.084,657,11569.79營業利益（損失）1,165,88129.94734,52927.073,366,75131.311,194,65917.90營業外收入及支出        　利息收入        　　利息收入合計123,7313.18246,5959.09506,5384.71702,18610.52　其他收入        　　其他收入合計2,2430.0610,0150.379,1900.0918,5660.28　其他利益及損失        　　其他利益及損失淨額129,7103.33-104,077-3.84-890,391-8.28244,0843.66　財務成本        　　財務成本淨額5,5540.145,5720.2119,7740.1816,8960.25　採用權益法認列之關聯企業及合資損益之份額        　　採用權益法認列之關聯企業及合資利益之份額-2,111-0.0500.00-2,111-0.0200.00　　採用權益法認列之關聯企業及合資損益之份額淨額-2,111-0.0500.00-2,111-0.0200.00　營業外收入及支出合計248,0196.37146,9615.42-396,548-3.69947,94014.21繼續營業單位稅前淨利（淨損）1,413,90036.31881,49032.492,970,20327.622,142,59932.11所得稅費用（利益）        　所得稅費用（利益）合計-59,177-1.52161,7995.96-598,682-5.57412,7026.18繼續營業單位本期淨利（淨損）1,473,07737.83719,69126.523,568,88533.191,729,89725.92本期淨利（淨損）1,473,07737.83719,69126.523,568,88533.191,729,89725.92其他綜合損益(淨額)        　不重分類至損益之項目        　　透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-28,047-0.72-9,487-0.35-68,687-0.64-19,078-0.29　　不重分類至損益之項目總額-28,047-0.72-9,487-0.35-68,687-0.64-19,078-0.29　後續可能重分類至損益之項目        　　國外營運機構財務報表換算之兌換差額-248,900-6.3914,2740.53-936,845-8.71249,4863.74　　後續可能重分類至損益之項目總額-248,900-6.3914,2740.53-936,845-8.71249,4863.74　其他綜合損益（淨額）-276,947-7.114,7870.18-1,005,532-9.35230,4083.45本期綜合損益總額1,196,13030.72724,47826.702,563,35323.841,960,30529.38淨利（損）歸屬於：        　母公司業主（淨利∕損）1,473,07737.83719,69126.523,568,88533.191,729,89725.92綜合損益總額歸屬於：        　母公司業主（綜合損益）1,196,13030.72724,47826.702,563,35323.841,960,30529.38基本每股盈餘        　基本每股盈餘合計3.99 1.99 9.66 4.71 稀釋每股盈餘        　稀釋每股盈餘合計3.97 1.98 9.62 4.67 資料來源:交易所公開資訊觀測站